Embecta (EMBC) EPS (Basic) Growth (1y) (2021 - 2026)
Embecta (EMBC) EPS (Basic) Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 25.48% |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | -31.18% |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 1.81% |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 18.95% |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 4.17% |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | -191.06% |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 37.39% |
| 10 | Embecta | 319.59 Mn | 101.39 Mn | 153.30 Mn | -53.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -53.62% |
| Mar 31, 2026 | -117.15% |
| Sep 30, 2025 | 78.87% |
| Jun 30, 2025 | 205.70% |
| Mar 31, 2025 | -19.53% |
| Sep 30, 2024 | 141.51% |
| Jun 30, 2024 | -4.08% |
| Mar 31, 2024 | 104.90% |
| Dec 31, 2023 | -43.27% |
| Sep 30, 2023 | 134.75% |
| Jun 30, 2023 | -75.43% |
| Mar 31, 2023 | -82.25% |
| Dec 31, 2022 | -64.43% |
| Sep 30, 2022 | -117.75% |
| Jun 30, 2022 | -40.41% |
| Mar 31, 2022 | -26.23% |
| Dec 31, 2021 | -6.17% |